Clinitech Laboratory Ltd (CTLLAB) Share Price & Fundamentals

What we do

Clinitech Laboratory Limited provides diagnostic and healthcare testing services through eight NABL-accredited labs in Navi Mumbai and Thane regions.

Founded in

2,010

Market share

Recognized as a trusted pathology lab with strong regional presence in Mumbai Metropolitan Area.

Problem solved

Provides accurate and timely diagnostic tests enabling better disease diagnosis and clinical decision-making.

Top clients or who we serve

Healthcare providers and patients in Navi Mumbai, Thane, and Raigad; mainly B2C through diagnostic testing services.

Key management

Jagdish Umakant Nayak, Managing Director; Jyoti Jagdish Nayak, Whole-time Director; Rahul Motilal Patil, CFO.

Our journey and innovations

Incorporated 2010, NABL accreditation in 2016, public listing in 2024; continuous expansion of diagnostic capabilities.

Where we operate

Operates labs and centers primarily in Navi Mumbai, Thane, and Raigad districts, Maharashtra, India.

Top products or what we offer

Clinical pathology, biochemical, immunology, hematology, microbiology, histopathology tests, and imaging diagnostics.

Top brands

Clinitech Diagnostic Centers – key regional pathology and imaging service provider with over 3 lakh tests annually.

Raw materials needed

-

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue predominantly recurring from regular diagnostic and healthcare testing services.

Our industry position

Regional leader in diagnostic services with steady growth and accredited quality standards.

Financial highlights

FY 2024-25 revenue Rs. 8.23 crore, net profit Rs. 39.47 lakhs; consistent growth from previous year.

Geographical revenue split

Revenue mainly from Maharashtra, focused on Navi Mumbai, Thane, and Raigad regions.

Order book

-

Whats driving growth

Expanded diagnostic capacity, NABL accreditation, rising healthcare demand, and recent public listing.

Our future plans

Focus on expanding healthcare service offerings, enhancing technology, and increasing revenue and profitability.

Our green promise

-

Our people and values

Experienced leadership with over 30 years in diagnostics; committed to patient care and quality standards.

Key challenges ahead

Competition in diagnostics sector, maintaining accreditation standards, and scaling operations sustainably.

Interesting facts

Conducts over 3 lakh tests annually in accredited labs; transitioned from private to public company in 2023.

Risks and strategy

Risk mitigation through quality accreditation, regulatory compliance, and diversification of service portfolio.